TLR1 |
MyD88/TRIAP |
CS |
Di- and tri-acylated lipopeptides |
Mø, B, MCs |
No variation in IBD |
TLR2 |
MyD88/TRIAP |
CS |
Bacterial lipoproteins or lipopeptides |
Mø, B, MCs |
Increased in active UC |
TLR3 |
TRIF |
IC |
Double-stranded RNA (viral infection) |
Mø, B, MCs, N, Myeloid DCs, IECs |
Increased in active UC and CD |
TLR4 |
MyD88/TRIAP, TRIF/TRAM |
CS |
LPS, free fatty acids |
Mø, B, MCs, N, Myeloid DCs, IECs |
Increased in UC and CD |
TLR5 |
MyD88 |
CS |
Bacterial flagellins |
Mø, Myeloid DCs, IECs |
Decreased in CD |
TLR6 |
MyD88/TRAF6 and NF-κB pathway |
CS |
Di- and tri-acylated lipopeptides |
Mø, B, MCs |
Increased in UC |
TLR7 |
MyD88 |
IC/Endosomal |
Single stranded RNA (viral inflammation) |
Mø |
Increased in UC |
TLR8 |
MyD88 |
IC/endosomal |
RNA degradation products specific to microorganism (GU-rich single stranded RNA) |
Mø, DCs |
Increased in UC |
TLR9 |
MyD88/TRAF6 |
IC |
Nucleid acid |
Mø, B, plasmacytoid DCs |
Increased in UC |